Oranair Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Salbutamol

Indications/Uses

Asthma & COPD.

Click to view Oranair detailed prescribing information

Dosage/Direction for Use

Adult Initially 2.5 mg as single dose, may be increased to 5 mg. May be repeated up to qid. Childn ≥12 yr Adult dose, 4-11 yr 2.5-5 mg up to qid.

Click to view Oranair detailed prescribing information

Overdosage

View Oranair overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity. Not to be used in the management of premature labor. Should not be used in threatened abortion.

Click to view Oranair detailed prescribing information

Special Precautions

Not to be injected or swallowed. Not to be the only or main treatment in patients w/ severe or unstable asthma. Caution in patients suffering from thyrotoxicosis; patients known to have received large doses of other sympathomimetic drugs; patients w/ acute severe asthma. Patients w/ underlying severe heart disease (eg, ischaemic heart disease, arrhythmia or severe heart failure) should be warned to seek medical advice if they experience chest pain or other symptoms of worsening heart disease. Risk of potentially serious hypokalaemia. Monitor serum K levels. Can induce reversible metabolic changes eg, increased blood glucose levels. Reports of lactic acidosis w/ high doses, mainly in patients w/ acute asthma exacerbation. Reports of acute angle-closure glaucoma in patients treated w/ combination of nebulised salbutamol & ipratropium Br. Risk of paradoxical bronchospasm. Pregnancy & lactation.

Click to view Oranair detailed prescribing information

Use In Pregnancy & Lactation

Click to view Oranair detailed prescribing information

Adverse Reactions

Fine tremor of skeletal muscle (particularly the hands), palpitations, tachycardia, nervous tension, headaches, peripheral vasodilatation, muscle cramps. Myocardial ischaemia. Hypersensitivity reactions including paradoxical bronchospasm, angioedema, urticaria, hypotension, collapse.

Click to view Oranair detailed prescribing information

Drug Interactions

Increased risk of hypokalaemia & monitoring K conc is recommended when used w/ corticosteroids, diuretics or xanthines.

Click to view Oranair detailed prescribing information

Storage

View Oranair storage conditions for details to ensure optimal shelf-life.

Description

View Oranair description for details of the chemical structure and excipients (inactive components).

Action

View Oranair mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antiasthmatic & COPD Preparations

ATC Classification

R03AC02 - salbutamol ; Belongs to the class of adrenergic inhalants, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.

Regulatory Classification

Presentation/Packing

Form

Oranair soln for inhalation 1 mg/mL

Packing/Price

2.5 mL x 25 × 1's;2.5 mL x 30 × 1's

Oranair

salbutamol

Manufacturer:

Legency Remedies

Distributor:

Orange Biotec